Yosipovitch G, Zeidler C, Apfelbacher CJ, Laquer V, Kim BS, Casillas M, Pierce E, Chen S, Qiao M, Agell H, Del Rosso J. Lebrikizumab Delivers Clinically Meaningful and Continuous Improvement in Itch-Free Days in Atopic Dermatitis Through One Year. J of Skin [Internet]. 2023Nov.13 [cited 2024Jul.3];7(6):s273. Available from: https://jofskin.org/index.php/skin/article/view/2387